INNOInnoCan Pharma Corporation

2.700CAD+8.00%Mkt Cap: 9.67M $P/E:

InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company …

Key Statistics

Company
Market Cap9.67M $
Enterprise Value5.07M $
Revenue (TTM)18.41M $
Gross Profit17.43M $
Net Income (TTM)-818.57K $
Revenue/Share4.105 USD
Last Price2.700 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees
CountryCA
SectorHealthcare
IndustryHousehold & Personal Products
ISINCA45783P1027
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-2.80
EV/Revenue0.28
P/S0.37
P/B1.31
EPS (TTM)-0.47
EPS (Forward)
52W Range
2.1803% of range21.00
52W High21.00 CAD
52W Low2.180 CAD
Profitability
Gross Margin89.93%
Oper. Margin-12.16%
EBITDA Margin-9.85%
Profit Margin-4.22%
ROE-20.08%
ROA-10.68%
Growth
Revenue Growth-17.10%
Earnings Growth
Cash Flow & Leverage
Operating CF360.49K $
CapEx (TTM)11.65K $
FCF Margin-2.10%
FCF Yield-3.99%
Net Debt-3.79M $
Net Debt/EBITDA2.09
Balance Sheet
Debt/Equity0.17
Current Ratio5.51
Quick Ratio4.06
Book Value/Sh1.598 CAD
Cash/Share1.473 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:65
Split DateSep 5, 2025
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.4.50M
Float3.58M
Insiders20.32%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short72
Short (prev mo.)223
Technical
SMA 502.917 (-7.4%)
SMA 2006.365 (-57.6%)
Beta-0.22
S&P 52W Chg18.16%
Avg Vol (30d)872
Avg Vol (10d)1.90K
Technical Indicators
RSI (14)42.2
MACD-0.2126
MACD Signal-0.1560
MACD Hist.-0.0565
BB Upper3.937 CAD
BB Middle3.167 CAD
BB Lower2.396 CAD
BB Width48.67%
ATR (14)0.2015 CAD
Vol Ratio (20d)0.38x